Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?-Reference-Cited by-同舟云学术

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Published:2019-01-04 Issue:3 Volume:49 Page:197-205
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Yamaguchi Masafumi,Shimamatsu Shinichiro,Edagawa Makoto,Hirai Fumihiko,Toyozawa Ryo,Nosaki Kaname,Seto Takashi,Takenoyama Mitsuhiro,Ichinose Yukito

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s00595-018-1751-7/fulltext.html

Reference31 articles.

1. Ginsberg RJ, Rubinstein LV, Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–22 (discussion 22–3)

2. network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non-small cell lung cancer version 2.2013. 2013. http://www.nccn.com .

3. Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, et al. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65(Suppl 3):iii1–27.

4. Ramnath N, Dilling TJ, Harris LJ, Kim AW, Michaud GC, Balekian AA, et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e314S–40S.

5. Vansteenkiste J, De Ruysscher D, Eberhardt WE, Lim E, Senan S, Felip E, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi89–98.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgery patterns and survival of T4N2 non-small cell lung cancer – A population-based analysis;Clinical Surgical Oncology;2024-03

2. Cutting-edge Nanotechnological Approaches for Lung Cancer Therapy;Current Drug Research Reviews;2022-11

3. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis;Interactive CardioVascular and Thoracic Surgery;2021-11-04

4. Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?;Lung Cancer;2020-12

5. The Positive Lymph Node Ratio Predicts Survival in T1−4N1−3M0 Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database;Frontiers in Oncology;2020-08-05